tiprankstipranks
BICO Group AB Class B (CLLKF)
:CLLKF

BICO Group AB Class B (CLLKF) Price & Analysis

Compare
35 Followers

CLLKF Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%1.56%96.43%
Insiders
1.56% Other Institutional Investors
96.43% Public Companies and
Individual Investors

CLLKF FAQ

What was BICO Group AB Class B’s price range in the past 12 months?
BICO Group AB Class B lowest stock price was $2.43 and its highest was $5.60 in the past 12 months.
    What is BICO Group AB Class B’s market cap?
    BICO Group AB Class B’s market cap is $275.20M.
      When is BICO Group AB Class B’s upcoming earnings report date?
      BICO Group AB Class B’s upcoming earnings report date is Apr 29, 2025 which is in 66 days.
        How were BICO Group AB Class B’s earnings last quarter?
        BICO Group AB Class B released its earnings results on Feb 19, 2025. The company reported $0.405 earnings per share for the quarter, beating the consensus estimate of -$0.022 by $0.427.
          Is BICO Group AB Class B overvalued?
          According to Wall Street analysts BICO Group AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does BICO Group AB Class B pay dividends?
            BICO Group AB Class B does not currently pay dividends.
            What is BICO Group AB Class B’s EPS estimate?
            BICO Group AB Class B’s EPS estimate is -0.09.
              How many shares outstanding does BICO Group AB Class B have?
              BICO Group AB Class B has 69,074,900 shares outstanding.
                What happened to BICO Group AB Class B’s price movement after its last earnings report?
                BICO Group AB Class B reported an EPS of $0.405 in its last earnings report, beating expectations of -$0.022. Following the earnings report the stock price went up 13.714%.
                  Which hedge fund is a major shareholder of BICO Group AB Class B?
                  Currently, no hedge funds are holding shares in CLLKF
                  ---

                  Company Description

                  BICO Group AB Class B

                  CELLINK AB is engaged in the development and commercialization of bioprinting technologies. Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications. The company's technology is used to print tissues such as liver, cartilage, skin, and even fully functional cancer tumors that can then be used to develop new cancer treatments.
                  ---

                  CLLKF Company Deck

                  ---

                  CLLKF Earnings Call

                  Q4 2025
                  0:00 / 0:00
                  Earnings Call Sentiment|Neutral
                  The earnings call reflects a challenging year for BICO with several operational improvements leading to a stronger EBITDA margin and a solid cash position. However, the company faced significant hurdles with negative sales growth, particularly in Lab Automation and the Chinese market. Despite these challenges, BICO is well-positioned with improved operational efficiencies and a strong cash flow, but the overall sales outlook remains cautious.Read More>
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Quantum-Si
                  10x Genomics
                  Pacific Biosciences
                  Illumina
                  Mueller Industries
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis